Cargando…
Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine
The biomaterial fibrin is widely used as a clinical tissue sealant in surgery. In preclinical research, fibrin is also extensively studied as a carrier material for growth factor delivery. In these applications, premature fibrin degradation leads to recurrent bleeding, tissue dehiscence and limited...
Autores principales: | Liu, Jialu, Solanki, Ani, White, Michael J. V., Hubbell, Jeffrey A., Briquez, Priscilla S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246914/ https://www.ncbi.nlm.nih.gov/pubmed/35773290 http://dx.doi.org/10.1038/s41536-022-00230-x |
Ejemplares similares
-
Antifibrinolytic Agents in Traumatic Haemorrhage
por: Coats, Tim, et al.
Publicado: (2005) -
Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009) -
α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2022) -
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010)